Sana Biotechnology, Inc. (SANA) Tops Q1 EPS by 3c

Sana Biotechnology, Inc. (NASDAQ: SANA) reported Q1 EPS of ($0.21), $0.03 better than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Sana Biotechnology, Inc. (SANA) click here.

You May Also Be Interested In

• Travere Therapeutics (TVTX) PT Raised to $65 at Guggenheim
• Penguin Solutions updates ClusterWareAI with AI agent and GPU tools
• Barclays sees global expansion intact, warns against market complacency